103 results on '"Noh, Young-Su"'
Search Results
2. ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
3. Effect of lanthanum group promoters on Cu/(mixture of ZnO and Zn-Al-spinnel-oxides) catalyst for methanol synthesis by hydrogenation of CO and CO2 mixtures
4. Dry reforming of methane over Ni/ZrO2-Al2O3 catalysts: Effect of preparation methods
5. Effect of catalytic reactor bed dilution on product distribution for Fischer-Tropsch synthesis over Ru/Co/Al2O3 catalyst
6. Combined steam and CO2 reforming of methane over La1-xSrxNiO3 perovskite oxides
7. Hydrocracking of FT-wax to fuels over non-noble metal catalysts
8. Studies on the synthesis of higher alcohol over modified Cu/ZnO/Al2O3 catalyst
9. Studies on the steam CO2 reforming of methane over ordered mesoporous nickel–magnesium–alumina catalysts
10. Hydrogenation of CO2 to synthetic natural gas over supported nickel catalyst: effect of support on methane selectivity
11. Synthesis and characterization of Al-modified SBA-15 for Fischer–Tropsch synthesis (FTS) reaction
12. CO/CO2 hydrogenation for the production of lighter hydrocarbons over SAPO-34 modified hybrid FTS catalysts
13. Hydrogenation of dibenzyltoluene and the catalytic performance of Pt/Al 2 O 3with various Pt loadings for hydrogen production from perhydro‐dibenzyltoluene
14. Development of A 360kW Bi-directional Battery Tester with Wide Voltage Output Range
15. Control Strategy of Resonant Load Identification for Free Zone Induction Heating Systems with WBG-based Multiple Inverters
16. A phase Ib trial of belvarafenib in combination with cobimetinib in patients with advanced solid tumors: Interim results of dose-escalation and patients with NRAS-mutant melanoma of dose-expansion.
17. Hydrogenation of dibenzyltoluene and the catalytic performance of Pt/Al2O3 with various Pt loadings for hydrogen production from perhydro‐dibenzyltoluene.
18. Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study
19. Preparation and Characterization of Ni/ZrTiAlOx Catalyst via Sol-Gel and Impregnation Methods for Low Temperature Dry Reforming of Methane
20. HM43239, a Novel Small Molecule Inhibitor of FLT3, in Acute Myeloid Leukemia (AML) with and without FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1/2 Study
21. Arvelexin from Brassica rapa suppresses NF-κB-regulated pro-inflammatory gene expression by inhibiting activation of IκB kinase
22. A Review on Catalysts Development for Steam Reforming of Biodiesel Derived Glycerol; Promoters and Supports
23. Studies on the Fischer-Tropsch synthesis over RuCo/SiC-Al2O3 structured catalyst
24. HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study
25. Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
26. Characterizations and Kinetic Studies for the Fischer Tropsch Synthesis Over Co/Al2O3 Catalyst
27. Hydrogen production by steam reforming of methane over nickel based structured catalysts supported on calcium aluminate modified SiC
28. Caffeoyloxy-5,6-dihydro-4-methyl-(2H)-pyran-2-one isolated from the leaves of Olinia usambarensis attenuates LPS-induced inflammatory mediators by inactivating AP-1 and NF-κB
29. A safety, pharmacokinetic, pharmacogenomic and population pharmacokinetic analysis of the third‐generation EGFR TKI, olmutinib (HM61713), after single oral administration in healthy volunteers
30. Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.
31. Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted condition
32. Dry reforming of methane over Ni/ZrO 2 -Al 2 O 3 catalysts: Effect of preparation methods
33. ARAFmutations confer resistance to the RAF inhibitor belvarafenib in melanoma
34. Effect of catalytic reactor bed dilution on product distribution for Fischer-Tropsch synthesis over Ru/Co/Al 2 O 3 catalyst
35. Nickel Supported on Mesoporous Alumina for Dry Reforming of Methane: Combustion Method
36. Development of a simple and sensitive HPLC-MS/MS method for determination of diazepam in human plasma and its application to a bioequivalence study
37. Hydrogenation of CO2 to synthetic natural gas over supported nickel catalyst: effect of support on methane selectivity
38. Characterizations and Kinetic Studies for the Fischer Tropsch Synthesis Over Co/Al2O3 Catalyst
39. First-in-human study of HM95573, a novel oral RAF inhibitor, in patients with solid tumors.
40. The Effect of Fe in Perovskite Catalysts for Steam CO2 Reforming of Methane
41. Synthesis and characterization of Al-modified SBA-15 for Fischer–Tropsch synthesis (FTS) reaction
42. Steam CO 2 reforming of methane over La 1−x Ce x NiO 3 perovskite catalysts
43. Hydrogen production by steam reforming of methane over mixed Ni/MgAl + CrFe 3 O 4 catalysts
44. Studies on the synthesis of higher alcohol over modified Cu/ZnO/Al2O3 catalyst.
45. Studies on the steam CO reforming of methane over ordered mesoporous nickel-magnesium-alumina catalysts.
46. Anti-inflammatory and anti-arthritic effects of new synthetic 3-(4-hydroxyphenyl)-4-(4-thiomethoxyphenyl)-1H-pyrrole-2,5-dione
47. The effect of promoters in La 0.9 M 0.1 Ni 0.5 Fe 0.5 O 3 (M = Sr, Ca) perovskite catalysts on dry reforming of methane
48. Anti-inflammatory Effects of the Methanol Extract of Polytrichum Commune via NF-κB Inactivation in RAW 264.7 Macrophage Cells
49. The effect of promoters in La0.9M0.1Ni0.5Fe0.5O3 (M = Sr, Ca) perovskite catalysts on dry reforming of methane.
50. Preparation and Characterization of Ni/ZrTiAlO x Catalyst via Sol-Gel and Impregnation Methods for Low Temperature Dry Reforming of Methane.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.